ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| Regenicin, Inc. Delisted | — | United States of America | — | 178 |
| AnorMED Inc. Delisted | — | Canada | — | 177 |
| Y-Biologics, Inc | 338840 | South Korea | — | 177 |
| OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC Delisted | OCTHF | United Kingdom | — | 176 |
| HEM Pharma Inc. | 376270 | South Korea | — | 174 |
| Onco-Innovations | ONCO | Canada | — | 172 |
| Sigilon Therapeutics Inc Delisted | SGTX | United States of America | — | 172 |
| Ambit Biosciences Corp Delisted | AMBI_old | United States of America | — | 171 |
| INCARA PHARMACEUTICALS CORP Delisted | — | United States of America | — | 171 |
| ENDOVASC INC Delisted | — | United States of America | — | 170 |
| LianBio Delisted | — | United States of America | — | 170 |
| BIOTRANSPLANT INC Delisted | — | United States of America | — | 169 |
| 024 Pharma, Inc. Delisted | — | United States of America | — | 168 |
| Dice Molecules Holdings LLC Delisted | DICE | United States of America | — | 168 |
| Forward Pharma A S Delisted | FWP | United States of America | — | 168 |
| Coley Pharmaceutical Group, Inc. Delisted | — | United States of America | — | 167 |
| Sharp Therapeutics Corp. | SHRX | Canada | — | 167 |
| Oncolix, Inc. Delisted | — | United States of America | — | 166 |
| Veritas In Silico Inc. | 130A | Japan | — | 166 |
| MegaPro Biomedical Co. Ltd. | — | Malaysia | — | 165 |
| 케미메디 Delisted | 205290 | South Korea | — | 164 |
| Ambrx Biopharma Cayman, Inc. Delisted | — | United States of America | — | 164 |
| Decibel Therapeutics Inc Delisted | DBTX | United States of America | — | 164 |
| Innovation1 Biotech Inc. Delisted | — | United States of America | — | 164 |
| NEUROPATHIX, INC. Delisted | — | United States of America | — | 164 |
| CORVAS INTERNATIONAL INC Delisted | — | United States of America | — | 163 |
| FUNCTIONAL TECHNOLOGIES CORP. Delisted | FEB | Canada | — | 163 |
| Acambis Plc Delisted | ACAMY | United States of America | — | 161 |
| MYND Life Sciences Inc. | MYND | Canada | — | 161 |
| GAMMACAN INTERNATIONAL INC Delisted | — | United States of America | — | 160 |
| Curocell Inc. | 372320 | South Korea | — | 159 |
| K Pharma,Inc. | 4896 | Japan | — | 159 |
| NeuroThera Labs Inc. | NTLX | Canada | — | 159 |
| Cuorips Inc. | 4894 | Japan | — | 158 |
| Laekna, Inc. | 2105 | Hong Kong | — | 158 |
| Viela Bio Inc Delisted | VIE | United States of America | — | 156 |
| Motif Bio plc Delisted | MTFB | United States of America | — | 155 |
| Wuhan YZY Biopharma Co., Ltd. | 2496 | Hong Kong | — | 155 |
| Xynomic Pharmaceuticals Holdings Inc Delisted | XYN | United States of America | — | 154 |
| Dimension Therapeutics Delisted | DMTX | United States of America | — | 152 |
| Neon Therapeutics, Inc. Delisted | — | United States of America | — | 152 |
| ALTEROLA BIOTECH INC. Delisted | — | United States of America | — | 151 |
| GLOBEIMMUNE INC Delisted | — | United States of America | — | 151 |
| LTR PHARMA LIMITED | LTP | Australia | — | 151 |
| SHAMAN PHARMACEUTICALS INC Delisted | — | United States of America | — | 150 |
| TISSUE REPAIR LTD | TRP | Australia | — | 150 |
| Advanced Proteome Therapeutics Corporation Delisted | APC.H | Canada | — | 149 |
| Pherecydes Pharma Delisted | ALPHE | France | — | 149 |
| SYNAPTIC PHARMACEUTICAL CORP Delisted | — | United States of America | — | 149 |
| Oncocross Co.,Ltd. | 382150 | South Korea | — | 148 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.